Rheumatoid Arthritis Clinical Trials in New York

Showing 3521-3540 of 4,168 trials

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

NCT00498927

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with recurrent glioblastoma multiforme or other malignant glioma.

Brain and Central Nervous System Tumors

Memorial Sloan Kettering Cancer Center47 participantsStarted Jun 2007

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

NCT01953679

To compare the pharmacodynamic effects of 2 continuous dose regimens of ulipristal acetate 5.0 and 10.0 mg-only oral contraception, versus a 24/4 day regimen of UPA 5.0 mg.

Focus: Estrogen-free Oral Contraception

Premier Research180 participantsStarted Mar 2014

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

COMPLETEDNA< 1 mile

GORE Flow Reversal System and GORE Embolic Filter Extension Study

NCT01343667

The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.

Carotid StenosisConstriction, PathologicCarotid Artery Diseases+8 more

W.L.Gore & Associates1,397 participantsStarted Apr 2011

Flagstaff, Arizona, United States • Newport Beach, California, United States • San Francisco, California, United States +36 more locations

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Rheumatoid Arthritis Trials in Other Cities

Blood and Marrow Transplant Clinical Research Network

Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

microEEG for Neonatal Apnea, Bradycardia and Desaturation

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

Intradiscal rhGDF-5 Phase I/II Clinical Trial

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants

Other Conditions in New York